Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer
- 1 December 2001
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 72 (6) , 1868-1876
- https://doi.org/10.1016/s0003-4975(01)03207-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Molecular biologic substaging of stage I lung cancer according to gender and histologyThe Annals of Thoracic Surgery, 2000
- A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Journal of Clinical Oncology, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCERHematology/Oncology Clinics of North America, 1997
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.Journal of Biological Chemistry, 1994
- Expression of the ERBB3 gene product in breast cancerBritish Journal of Cancer, 1992
- Protein Tyrosine Kinase Growth Factor Receptors and their Ligands in Development, Differentiation, and CancerAdvances in Cancer Research, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991